U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891208) titled 'Nasal High Flow Oxygen in Patients With Lower-Limb Ischaemia' on Oct. 16.
Brief Summary: A prospective, single arm pilot efficacy study designed to evaluate the physiological and symptomatic effects of normobaric Nasal High Flow (NHF) oxygen therapy in patients with lower limb ischaemia experiencing rest pain and/or wound related pain.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Nasal High Flow Oxygen Therapy Effect on Lower Limb Ischaemia
Intervention:
DEVICE: Nasal high flow oxygen
Normobaric nasal high flow oxygen for lower limb ischaemia
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Fisher and P...